Non-alcoholic fatty liver disease: An early mediator predicting metabolic syndrome in obese children?

Table 4 Metabolic syndrome in obese patients diagnosed by B-ultrasound

	Scale (0) (n = 274)	Scale (1) (n = 105)	Scale (2-3) (n = 482)	P
Hypertension
No	206	54	280
Yes	68	51	202	< 0.05
OR (95% CI)	1.0	2.87 (1.29-6.37)	2.18 (1.27-3.75)
Dyslipidemia
No	232	57	210
Yes	42	48	272	< 0.01
OR (95% CI)	1.0	5.21 (2.23-12.18)	7.99 (4.34-14.73)
Impaired fasting glucose
No	269	102	435
Yes	5	3	47	< 0.05
OR (95% CI)	1.0	1.0 (0.1-9.94)	3.65 (1.04-12.85)
Impaired glucose tolerance
No	261	99	432
Yes	13	6	50	> 0.05
OR (95% CI)	1.0	1.53 (0.27-8.74)	2.9 (0.95-8.87)
Hyperuricacidemia
No	232	81	301
Yes	42	24	181	< 0.01
OR (95% CI)	1.0	1.83 (0.71-4.74)	3.76 (2.03-6.96)
MS
No	241	75	324
Yes	33	30	158	< 0.01
OR (95% CI)	1.0	3.10 (1.20-8.00)	3.77 (1.90-7.47)

MS: Metabolic syndrome; OR: Odds ratio; CI: Confidence interval.